Quantum biopharma announces corporate updates

Toronto, ontario--(newsfile corp. - september 26, 2025) - quantum biopharma ltd. (nasdaq: qntm) (cse: qntm) (fse: 0k91) (upstream: qntm) ("quantum biopharma" or the "company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, today announces the following corporate updates: grant of restricted stock units the company's board of directors (the "board") authorized and approved the grant of restricted share units (each, an "rsu") pursuant to the company's omnibus equity incentive plan (the "equity incentive plan").
QNTM Ratings Summary
QNTM Quant Ranking